Home » Stocks » Applied Therapeutics

Applied Therapeutics, Inc. (APLT)

Stock Price: $22.29 USD -1.17 (-4.99%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 500.09M
Revenue (ttm) n/a
Net Income (ttm) -68.77M
Shares Out 22.44M
EPS (ttm) -3.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $22.29
Previous Close $23.46
Change ($) -1.17
Change (%) -4.99%
Day's Open 23.61
Day's Range 22.08 - 23.73
Day's Volume 71,315
52-Week Range 10.75 - 57.39

More Stats

Market Cap 500.09M
Enterprise Value 363.45M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 22.44M
Float 13.08M
EPS (basic) -4.06
EPS (diluted) -3.68
FCF / Share -2.49
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.61M
Short Ratio 11.02
Short % of Float 12.35%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 4.04
Revenue n/a
Operating Income -69.16M
Net Income -68.77M
Free Cash Flow -55.01M
Net Cash 136.63M
Net Cash / Share 6.09
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -44.19%
ROE -80.81%
ROIC -203.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 6
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$60.50*
(171.42% upside)
Low
42.0
Current: $22.29
High
85.0
Target: 60.50
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017
Revenue---
Operating Income-45.58-13.52-4.29
Net Income-45.51-16.52-4.28
Shares Outstanding12.835.485.41
Earnings Per Share-3.55-3.01-0.79
Operating Cash Flow-36.31-11.18-3.20
Free Cash Flow-36.31-11.18-3.20
Cash & Equivalents38.8518.753.28
Total Debt2.04--
Net Cash / Debt36.8218.753.28
Assets48.3920.253.29
Liabilities15.784.430.99
Book Value32.61-19.59-3.96
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Applied Therapeutics, Inc.
Country United States
Employees 18
CEO Shoshana Shendelman

Stock Information

Ticker Symbol APLT
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: APLT
IPO Date May 14, 2019

Description

Applied Therapeutics, a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy; and AT-003 that is in phase I clinical trial for the treatment diabetic retinopathy. The company's preclinical stage products include AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.